U.S. Markets closed

Trillium: 4Q Earnings Snapshot

MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Monday reported a loss of $6.5 million in its fourth quarter.

The Mississauga, Ontario-based company said it had a loss of 42 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 66 cents per share.

For the year, the company reported that its loss narrowed to $32.8 million, or $2.36 per share.

In the final minutes of trading on Monday, the company's shares hit 67 cents. A year ago, they were trading at $7.25.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TRIL at https://www.zacks.com/ap/TRIL